Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Beta Bionics, Inc. Common Stock, Common Stock

BBNX

NMQ

$21.81

-$0.15

(-0.68%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$945.12M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

196.58K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$21.35 L

$24.5 H

$21.81

About Beta Bionics, Inc. Common Stock, Common Stock

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California. more

Returns

Data is not properly formatted.

Time Frame	BBNX		S&P500
1-Week Return	-0.82%%	%	1.35%%
1-Month Return	-7.7%%	%	1.42%%

Financials

	Dec '22	Dec '23
Total Revenue	179.00K	11.99M	[{"date":"2022-12-31","value":1.49,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	5.69M	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit	179.00K	6.31M	[{"date":"2022-12-31","value":2.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	100.00%	52.59%	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":52.59,"profit":true}]

Operating Expenses	66.02M	47.84M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":72.47,"profit":true}]
Operating Income	(65.84M)	(35.85M)	[{"date":"2022-12-31","value":-6584400000,"profit":false},{"date":"2023-12-31","value":-3585000000,"profit":false}]
Total Non-Operating Income/Expense	1.09M	(8.25M)	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-754.71,"profit":false}]
Pre-Tax Income	(64.75M)	(44.10M)	[{"date":"2022-12-31","value":-6475100000,"profit":false},{"date":"2023-12-31","value":-4409900000,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(64.75M)	(44.10M)	[{"date":"2022-12-31","value":-6475100000,"profit":false},{"date":"2023-12-31","value":-4409900000,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(64.75M)	(44.10M)	[{"date":"2022-12-31","value":-6475100000,"profit":false},{"date":"2023-12-31","value":-4409900000,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Dec '22	Dec '23
Total Revenue	-	6601.12%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	3424.02%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	-	(47.41%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Operating Expenses	-	(27.53%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Operating Income	-	(45.55%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	(854.71%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Pre-Tax Income	-	(31.89%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(31.89%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(31.89%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Dec '23
Total Revenue	8.35M	[{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	3.29M	[{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit	5.06M	[{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	60.62%	[{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	16.72M	[{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(8.37M)	[{"date":"2023-12-31","value":-836700000,"profit":false}]
Total Non-Operating Income/Expense	(10.48M)	[{"date":"2023-12-31","value":-1048100000,"profit":false}]
Pre-Tax Income	(18.85M)	[{"date":"2023-12-31","value":-1884800000,"profit":false}]
Income Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(18.85M)	[{"date":"2023-12-31","value":-1884800000,"profit":false}]
Income From Discontinued Operations	-	[{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(18.85M)	[{"date":"2023-12-31","value":-1884800000,"profit":false}]

EPS (Diluted)	-	[{"date":"2023-12-31","value":"-","profit":true}]

	Dec '23
Total Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	[{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	[{"date":"2023-12-31","value":"-","profit":true}]
Operating Income	-	[{"date":"2023-12-31","value":"-","profit":true}]
Total Non-Operating Income/Expense	-	[{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income From Discontinued Operations	-	[{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	[{"date":"2023-12-31","value":"-","profit":true}]

EPS (Diluted)	-	[{"date":"2023-12-31","value":"-","profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	28.47M	103.62M	[{"date":"2022-12-31","value":27.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	7.06M	6.42M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.92,"profit":true}]
Total Assets	35.53M	110.04M	[{"date":"2022-12-31","value":32.29,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	8.87M	10.61M	[{"date":"2022-12-31","value":83.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	196.69M	302.54M	[{"date":"2022-12-31","value":65.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	205.56M	313.14M	[{"date":"2022-12-31","value":65.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	(185.56M)	(229.66M)	[{"date":"2022-12-31","value":-18556500000,"profit":false},{"date":"2023-12-31","value":-22966400000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	(170.03M)	(203.10M)	[{"date":"2022-12-31","value":-17003400000,"profit":false},{"date":"2023-12-31","value":-20310500000,"profit":false}]

Total Liabilities & Shareholders Equity	35.53M	110.04M	[{"date":"2022-12-31","value":32.29,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	-	264.00%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	(9.08%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Total Assets	-	209.74%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	19.52%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	-	53.82%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	52.34%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	23.76%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	19.45%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	209.74%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '23	Sep '24
Total Assets
Current Assets	103.62M	82.56M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":79.67,"profit":true}]
Non-current Assets	6.42M	14.38M	[{"date":"2023-12-31","value":44.63,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Assets	110.04M	96.94M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":88.09,"profit":true}]

Total Liabilities
Current Liabilities	10.61M	17.88M	[{"date":"2023-12-31","value":59.32,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Non-current Liabilities	302.54M	307.91M	[{"date":"2023-12-31","value":98.26,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Liabilities	313.14M	325.79M	[{"date":"2023-12-31","value":96.12,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Retained Earnings	(229.66M)	(278.63M)	[{"date":"2023-12-31","value":-22966400000,"profit":false},{"date":"2024-09-30","value":-27862900000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Shareholders' equity	(203.10M)	(228.85M)	[{"date":"2023-12-31","value":-20310500000,"profit":false},{"date":"2024-09-30","value":-22884700000,"profit":false}]

Total Liabilities & Shareholders Equity	110.04M	96.94M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-09-30","value":88.09,"profit":true}]

	Dec '23	Sep '24
Total Assets
Current Assets	-	(20.33%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":null,"profit":false}]
Non-current Assets	-	124.07%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Assets	-	(11.91%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	68.59%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Non-current Liabilities	-	1.77%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Liabilities	-	4.04%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Retained Earnings	-	21.32%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Shareholders' equity	-	12.67%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(11.91%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":null,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	(60.21M)	(32.45M)	[{"date":"2022-12-31","value":-6020800000,"profit":false},{"date":"2023-12-31","value":-3244500000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	56.78M	101.03M	[{"date":"2022-12-31","value":56.2,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	(4.20M)	(1.11M)	[{"date":"2022-12-31","value":-419500000,"profit":false},{"date":"2023-12-31","value":-110900000,"profit":false}]

Free Cash Flow
Free Cash Flow	(60.98M)	(32.85M)	[{"date":"2022-12-31","value":-6098000000,"profit":false},{"date":"2023-12-31","value":-3284700000,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	(46.11%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	77.92%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	-	(73.56%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(46.13%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

	Dec '23
Operating Activities
Net Operating Cash Flow	(6.35M)	[{"date":"2023-12-31","value":-634700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	9.00K	[{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	(75.95M)	[{"date":"2023-12-31","value":-7594600000,"profit":false}]

Free Cash Flow
Free Cash Flow	(6.66M)	[{"date":"2023-12-31","value":-666000000,"profit":false}]

	Dec '23
Operating Activities
Net Operating Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Net Change in Cash	-	[{"date":"2023-12-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	BBNX
Current Ratio	4.62
Quick Ratio	3.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BBNX
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	BBNX
Debt Ratio Lower is generally better. Negative is bad.	3.36
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-2.36

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BBNX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	17.82
P/B	0.00
Price/FCF	NM
EV/R	16.81
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Beta Bionics, Inc. Common Stock share price today?

Beta Bionics, Inc. Common Stock (BBNX) share price today is $21.81

Can Indians buy Beta Bionics, Inc. Common Stock shares?

Yes, Indians can buy shares of Beta Bionics, Inc. Common Stock (BBNX) on Vested. To buy Beta Bionics, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BBNX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Beta Bionics, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Beta Bionics, Inc. Common Stock (BBNX) via the Vested app. You can start investing in Beta Bionics, Inc. Common Stock (BBNX) with a minimum investment of $1.

How to invest in Beta Bionics, Inc. Common Stock shares from India?

You can invest in shares of Beta Bionics, Inc. Common Stock (BBNX) via Vested in three simple steps:

Click on Sign Up or Invest in BBNX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Beta Bionics, Inc. Common Stock shares

What is Beta Bionics, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Beta Bionics, Inc. Common Stock (BBNX) is $24.5. The 52-week low price of Beta Bionics, Inc. Common Stock (BBNX) is $21.35.

What is Beta Bionics, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Beta Bionics, Inc. Common Stock (BBNX) is 0.00

What is the Market Cap of Beta Bionics, Inc. Common Stock?

The market capitalization of Beta Bionics, Inc. Common Stock (BBNX) is $945.12M

What is Beta Bionics, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Beta Bionics, Inc. Common Stock is BBNX